UNUM THERAPEUTICS INC's ticker is UMRX and the CUSIP is 903214104. A total of 26 filers reported holding UNUM THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $7,866,000 | +408.8% | 3,361,535 | 0.0% | 8.14% | +392.2% |
| Q2 2020 | $1,546,000 | +12.2% | 3,361,535 | 0.0% | 1.65% | -43.3% |
| Q1 2020 | $1,378,000 | -43.1% | 3,361,535 | 0.0% | 2.91% | -30.9% |
| Q4 2019 | $2,420,000 | -50.0% | 3,361,535 | 0.0% | 4.22% | -47.1% |
| Q3 2019 | $4,840,000 | -45.0% | 3,361,535 | 0.0% | 7.97% | -15.4% |
| Q2 2019 | $8,807,000 | -40.3% | 3,361,535 | 0.0% | 9.42% | -32.1% |
| Q1 2019 | $14,757,000 | -0.2% | 3,361,535 | 0.0% | 13.86% | -18.6% |
| Q4 2018 | $14,791,000 | -57.3% | 3,361,535 | 0.0% | 17.03% | -7.1% |
| Q3 2018 | $34,624,000 | -28.2% | 3,361,535 | 0.0% | 18.32% | -13.7% |
| Q2 2018 | $48,238,000 | +29.2% | 3,361,535 | 0.0% | 21.23% | -24.8% |
| Q1 2018 | $37,347,000 | – | 3,361,535 | – | 28.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 3,361,535 | $37,347,000 | 28.23% |
| Novo Holdings A/S | 665,181 | $31,669,000 | 3.97% |
| New Leaf Venture Partners, L.L.C. | 550,000 | $6,111,000 | 3.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,081,545 | $12,016,000 | 1.32% |
| SABBY MANAGEMENT, LLC | 1,106,445 | $12,292,000 | 0.73% |
| Monashee Investment Management LLC | 175,000 | $1,944,000 | 0.54% |
| DC Investments Management, LLC | 35,524 | $395,000 | 0.26% |
| Athanor Capital, LP | 22,300 | $248,000 | 0.12% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 225,000 | $2,499,000 | 0.07% |
| Schonfeld Strategic Advisors LLC | 73,000 | $811,000 | 0.06% |